(MENAFN- Comserve)
Shibuya-ku, Tokyo, Japan, Japan, Jul 05, 2022, 07:02 /Comserve / -- Heparin is a sulfur-containing polysaccharide that functions as a blood thinner.
Heparin is a sulfur-containing polysaccharide that functions as a blood thinner. Heparin is used to treat heart conditions that include unstable angina and prevent the development of blood clots inside blood vessels. Heparin is also used in dialysis treatment while blood transfusion and post-surgeries. Heparin is generally injected directly into the muscle or the veins to break down the clots and maintain an easy flow of the blood. The Heparin Sales Market is expected to grow at the rate of 5.2% CAGR by 2031. One of the key factors to compel the heparin sales market growth is the rising old population affected mainly by venous thrombosis. Venous thromboembolism (VTE) is the most common disorder in the old population; it can occur at any age. The prevalence rate of numerous diseases such as heart failure can result in thrombosis and most commonly occur in the geriatric population compared to the young age population. However, the adverse impacts of heparin are the key impeding factor of the market.
Download PDF Sample Report For More Information@
Heparin Sales Market on the basis of Type
• Low Molecular Weight Heparin
• Ultra-low Molecular Weight Heparin
• Unfractionated Heparin
Heparin Sales Market on the basis of Application
• Venous Thromboembolism
• Atrial Fibrillation
• Renal Impairment
• Coronary Artery Disease
• Others
Heparin Sales Market on the basis of End Use
• Outpatient
• Inpatient
Heparin Sales Market on the basis of Geography
• North America
• Europe
• Asia Pacific
• Rest of the World
The low molecular weight heparin segment has the most significant share in the market. This is due to the high anticipated anticoagulant effect of the product. Moreover, the significant share is due to the high adoption of the low molecular weight heparin in the developed countries, the high pricing of these product offerings, and the more safety profiles of this type of product compared to other products.
Further, the venous thromboembolism segment is expected to register the highest growth rate over the forecasted years. The highest growth is attributed to the increasing awareness about thrombosis and the increasing cases of venous thromboembolism. The venous thromboembolism is further categorized into pulmonary embolism (PE) and deep vein thrombosis (DVT).
As per the end-user, the market is bifurcated into outpatient and inpatient. The outpatient segment is projected to have a substantial growth rate in the market. The preference for a subcutaneous route of administration among the patients is increasing, which is a key factor for the segment growth. Moreover, the cost of outpatient treatment is low when compared to inpatient hospital costs.
North America has held a maximum share in the heparin sales market compared to other regions. The maximum share is accredited to the growing injuries in sports and rising cardiovascular disorders. In addition, the huge healthcare expenditure levels, rising patient awareness, and experienced healthcare infrastructure in this region are the factors attributed to the region's maximum share.
Few factors that are majorly accelerating the global heparin market growth are the rising number of accidents and medical surgeries globally, which is increasing demand for heparin. The growing disorders such as cardiovascular disorders will spur the demand for heparin. An increase in the investments to develop healthcare infrastructure and the increasing awareness among patients are also expected to boost the market demand.
Request A Free Sample to Learn More About This Report@
The major market companies of the heparin sales market include Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd., Aspen Pharmacare Holdings Ltd., Baxter International Inc., Laboratorios Farmaceuticos Rovi SA, Eisai Co. Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Mylan NV, Pfizer Inc., and Sanofi S.A.
Henceforth, the increasing prevalence of the diseases such as coronary heart disease and myocardial infections and the increasing number of accidents and injuries lead to blood clots during surgeries. Heparin is playing a prominent role in preventing blood clots from forming.
• This report of the heparin sales market consists of qualitative factors such as factors propelling and restraining and generating opportunities.
• This study depicts the competitive analysis of significant players in the heparin sales market and their strategic developments in the product.
• This research provides the analysis based on qualitative and quantitative of the market segmented.
• Additionally, this report consists of actual market shares and forecasts for all the segments which are mentioned in the report.
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
MENAFN05072022004694010674ID1104480001
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.